Rankings
▼
Calendar
XNCR Q2 2022 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena
XNCR
Xencor, Inc.
$890M
Q2 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$30M
-55.3% YoY
Gross Profit
-$17M
-56.0% margin
Operating Income
-$28M
-92.8% margin
Net Income
-$34M
-112.6% margin
EPS (Diluted)
$-0.67
QoQ Revenue Growth
-64.7%
Cash Flow
Operating Cash Flow
$44M
Free Cash Flow
$30M
Stock-Based Comp.
$13M
Balance Sheet
Total Assets
$851M
Total Liabilities
$109M
Stockholders' Equity
$742M
Cash & Equivalents
$49M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$30M
$67M
-55.3%
Gross Profit
-$17M
$18M
-194.2%
Operating Income
-$28M
$9M
-408.1%
Net Income
-$34M
$52M
-165.0%
Revenue Segments
Royalties
$30M
99%
Research collaboration
$200,000
1%
← FY 2022
All Quarters
Q3 2022 →